Cite

HARVARD Citation

    Wei, Y. et al. (2022). Strategies to evaluate potential effector function of glycan variants: a case study of ordesekimab (AMG 714 or PRV-015). Journal of immunotoxicology. 19 (1), pp. 109-116. [Online]. 
  
Back to record